Skip to main content
Antengene Corporation Limited logo

Antengene Corporation Limited — Investor Relations & Filings

Ticker · 6996 LEI · 655600N0NSGOMS4CVH68 HKEX Manufacturing
Open in API
Filings indexed 305 across all filing types
Latest filing 2026-04-29 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 6996

About Antengene Corporation Limited

http://www.antengene.com

Antengene Corporation Limited is a commercial-stage, R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel oncology therapeutics. The company's pipeline includes proprietary programs advancing to pivotal trials and commercialized assets such as selinexor and eltanexor. Antengene aims to deliver advanced anti-cancer drugs to patients across Greater China, the Asia Pacific region, and international markets.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for the company’s Annual General Meeting, used to solicit shareholder votes and provide instructions for appointing proxies. This falls under materials sent to shareholders to request votes for a meeting, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-29 English
NOTICE OF THE ANNUAL GENERAL MEETING
AGM Information Classification · 1% confidence The document is the official notice of the Annual General Meeting (AGM) of Antengene Corporation Limited, detailing the date, time, venue, resolutions to be proposed, and voting arrangements. It is clearly an AGM notice rather than the full Annual Report, earnings release, or proxy solicitation materials. Therefore, it fits the “AGM Information” category (Code: AGM-R).
2026-04-29 English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF THE AUDITOR; (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSO
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular sent in advance of the Annual General Meeting. It contains proposals for general mandates, re-election of directors, re-appointment of auditor, amendments to articles, explanatory statements, and notice of meeting with proxy voting instructions. This format matches a ‘Proxy Solicitation & Information Statement’ (PSI), as it requests shareholder votes rather than presenting financial results or audit opinions.
2026-04-29 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is a regulatory announcement under Hong Kong Listing Rule 13.51(1) notifying shareholders of proposed amendments to the company’s memorandum and articles of association and the adoption of a new amended and restated constitution, which are internal governance instruments. It does not contain full meeting materials or Q&A (excluding CT or PSI), nor financial statements or operational performance. This relates directly to the company’s governance framework and internal rules, matching the Governance Information category.
2026-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a standard HKEX listing rule Form FF301 – a monthly return of equity issuer share capital movements (authorized capital, issued shares, treasury shares, share options, etc.) under Chapter 19B. It is a regulatory compliance filing to the Stock Exchange rather than an earnings report, dividend notice, or proxy statement. It does not announce a specific new share issue (no changes occurred), but rather provides the mandated periodic regulatory disclosure. Therefore it best fits the “Regulatory Filings” category (RNS).
2026-04-09 English
GRANT OF SHARE OPTIONS AND RSUS
Remuneration Information Classification · 1% confidence The document is an exchange announcement under Listing Rule 17.06A disclosing grants of share options and RSUs under the company’s incentive schemes, including details of recipients, vesting, exercise price, clawback, and approvals. This is a report of executive and employee compensation rather than an earnings release, board change, or capital transaction. It falls under Remuneration Information (reporting detailed compensation for directors and executives).
2026-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.